KRISTIN PEGO: Open Payments
NPI 1508178179 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,127 in 11 payments from 7 companies in 2025. Trend: 2023 $408 · 2024 $855 · 2025 $1,127
Honoraria: $923Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| PharmaEssentia USA Corporation | 5 | $1,001 |
| Astellas Pharma US Inc | 1 | $31 |
| GENZYME CORPORATION | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $22 |
| PFIZER INC. | 1 | $17 |
| Syndax Pharmaceuticals, Inc. | 1 | $15 |
| Celgene Corporation | 1 | $14 |
Products named: BESREMI, Cresemba, SARCLISA, Orserdu, ELIQUIS, REVUFORJ, REBLOZYL.
Industry payments across NY — which companies pay providers there.
